<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-08-16" modified="2020-04-22" version="164">
<accession>Q6PKG0</accession>
<accession>O94836</accession>
<accession>Q8N4M2</accession>
<accession>Q8NB73</accession>
<accession>Q9UFD7</accession>
<name>LARP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>La-related protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>La ribonucleoprotein domain family member 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">LARP1</name>
<name type="synonym">KIAA0731</name>
<name type="synonym">LARP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-816 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2008-02" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Calvo F."/>
<person name="Matallanas D."/>
<person name="Cooper W.N."/>
<person name="Kolch W."/>
<person name="Heiserich L."/>
<person name="Boulahbel H."/>
<person name="Gottlieb E."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-26; 115-123; 167-185; 252-265; 357-366; 410-422; 429-473; 524-539; 579-597; 643-654; 695-703; 718-778; 904-924; 937-944; 949-964 AND 1004-1017</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>PHOSPHORYLATION AT THR-526 AND SER-774</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Colon carcinoma</tissue>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="DNA Res." volume="5" first="277" last="286">
<title>Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Suyama M."/>
<person name="Kikuno R."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="9872452"/>
<dbReference type="DOI" id="10.1093/dnares/5.5.277"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 123-1096 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 538-1096</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-521; THR-526; SER-627; SER-766 AND SER-774</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-845</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="1952" last="1967">
<title>Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction.</title>
<authorList>
<person name="Tang L.-Y."/>
<person name="Deng N."/>
<person name="Wang L.-S."/>
<person name="Dai J."/>
<person name="Wang Z.-L."/>
<person name="Jiang X.-S."/>
<person name="Li S.-J."/>
<person name="Li L."/>
<person name="Sheng Q.-H."/>
<person name="Wu D.-Q."/>
<person name="Li L."/>
<person name="Zeng R."/>
</authorList>
<dbReference type="PubMed" id="17693683"/>
<dbReference type="DOI" id="10.1074/mcp.m700120-mcp200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75 AND SER-90</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-627</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-143; SER-165; SER-517; SER-521; THR-526; SER-627; SER-631; THR-649; THR-724; SER-774; SER-824 AND SER-851</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; THR-526 AND SER-774</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-90; SER-627; SER-631; THR-724 AND SER-824</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-892 AND LYS-1017</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="5542" last="5553">
<title>The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration.</title>
<authorList>
<person name="Burrows C."/>
<person name="Abd Latip N."/>
<person name="Lam S.J."/>
<person name="Carpenter L."/>
<person name="Sawicka K."/>
<person name="Tzolovsky G."/>
<person name="Gabra H."/>
<person name="Bushell M."/>
<person name="Glover D.M."/>
<person name="Willis A.E."/>
<person name="Blagden S.P."/>
</authorList>
<dbReference type="PubMed" id="20430826"/>
<dbReference type="DOI" id="10.1093/nar/gkq294"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH MRNA; PABPC1; EIF4E AND EIF4G1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143; SER-220; THR-376; SER-521; THR-526; SER-548; SER-627; SER-631; THR-649; SER-766 AND SER-774</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-143; SER-215; SER-220; SER-521; THR-526; SER-548; SER-627; SER-631; SER-766; SER-774 AND TYR-777</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="FEBS Lett." volume="587" first="2173" last="2178">
<title>LARP1 specifically recognizes the 3' terminus of poly(A) mRNA.</title>
<authorList>
<person name="Aoki K."/>
<person name="Adachi S."/>
<person name="Homoto M."/>
<person name="Kusano H."/>
<person name="Koike K."/>
<person name="Natsume T."/>
</authorList>
<dbReference type="PubMed" id="23711370"/>
<dbReference type="DOI" id="10.1016/j.febslet.2013.05.035"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PABPC1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-143; THR-376; SER-517; SER-521; THR-526; SER-548; SER-591; SER-627; THR-649; SER-766; SER-774; THR-785; THR-788; SER-824 AND SER-1089</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="J. Transl. Med." volume="11" first="272" last="272">
<title>LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma.</title>
<authorList>
<person name="Xie C."/>
<person name="Huang L."/>
<person name="Xie S."/>
<person name="Xie D."/>
<person name="Zhang G."/>
<person name="Wang P."/>
<person name="Peng L."/>
<person name="Gao Z."/>
</authorList>
<dbReference type="PubMed" id="24159927"/>
<dbReference type="DOI" id="10.1186/1479-5876-11-272"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Genes Dev." volume="28" first="357" last="371">
<title>Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation.</title>
<authorList>
<person name="Tcherkezian J."/>
<person name="Cargnello M."/>
<person name="Romeo Y."/>
<person name="Huttlin E.L."/>
<person name="Lavoie G."/>
<person name="Gygi S.P."/>
<person name="Roux P.P."/>
</authorList>
<dbReference type="PubMed" id="24532714"/>
<dbReference type="DOI" id="10.1101/gad.231407.113"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH RPTOR; EIF4A1 AND PABPC1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-90; SER-627; SER-631; THR-649; SER-766 AND SER-1040</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-311</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2016" name="PLoS Pathog." volume="12" first="E1005357" last="E1005357">
<title>Characterization of RyDEN (C19orf66) as an interferon-stimulated cellular inhibitor against dengue virus replication.</title>
<authorList>
<person name="Suzuki Y."/>
<person name="Chin W.X."/>
<person name="Han Q."/>
<person name="Ichiyama K."/>
<person name="Lee C.H."/>
<person name="Eyo Z.W."/>
<person name="Ebina H."/>
<person name="Takahashi H."/>
<person name="Takahashi C."/>
<person name="Tan B.H."/>
<person name="Hishiki T."/>
<person name="Ohba K."/>
<person name="Matsuyama T."/>
<person name="Koyanagi Y."/>
<person name="Tan Y.J."/>
<person name="Sawasaki T."/>
<person name="Chu J.J."/>
<person name="Vasudevan S.G."/>
<person name="Sano K."/>
<person name="Yamamoto N."/>
</authorList>
<dbReference type="PubMed" id="26735137"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1005357"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PABPC1 AND SHFL</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="15996" last="16020">
<title>La-related protein 1 (LARP1) represses terminal oligopyrimidine (TOP) mRNA translation downstream of mTOR complex 1 (mTORC1).</title>
<authorList>
<person name="Fonseca B.D."/>
<person name="Zakaria C."/>
<person name="Jia J.J."/>
<person name="Graber T.E."/>
<person name="Svitkin Y."/>
<person name="Tahmasebi S."/>
<person name="Healy D."/>
<person name="Hoang H.D."/>
<person name="Jensen J.M."/>
<person name="Diao I.T."/>
<person name="Lussier A."/>
<person name="Dajadian C."/>
<person name="Padmanabhan N."/>
<person name="Wang W."/>
<person name="Matta-Camacho E."/>
<person name="Hearnden J."/>
<person name="Smith E.M."/>
<person name="Tsukumo Y."/>
<person name="Yanagiya A."/>
<person name="Morita M."/>
<person name="Petroulakis E."/>
<person name="Gonzalez J.L."/>
<person name="Hernandez G."/>
<person name="Alain T."/>
<person name="Damgaard C.K."/>
</authorList>
<dbReference type="PubMed" id="25940091"/>
<dbReference type="DOI" id="10.1074/jbc.m114.621730"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PABPC1; RPTOR AND THE MTORC1 COMPLEX</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 497-SER--PRO-507; PHE-505; 966-PHE--ILE-970 AND PHE-966</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2017" name="Elife" volume="6">
<title>LARP1 functions as a molecular switch for mTORC1-mediated translation of an essential class of mRNAs.</title>
<authorList>
<person name="Hong S."/>
<person name="Freeberg M.A."/>
<person name="Han T."/>
<person name="Kamath A."/>
<person name="Yao Y."/>
<person name="Fukuda T."/>
<person name="Suzuki T."/>
<person name="Kim J.K."/>
<person name="Inoki K."/>
</authorList>
<dbReference type="PubMed" id="28650797"/>
<dbReference type="DOI" id="10.7554/elife.25237"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RPTOR; PABPC1; EIF4E AND EIF4G1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-766; THR-769; THR-770; THR-782; THR-785; THR-797; SER-824; SER-847; SER-851; SER-861; THR-865; SER-868 AND SER-1058</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF SER-766; THR-769; SER-847 AND SER-1058</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2017" name="Mol. Cell" volume="67" first="55" last="70">
<title>Autogenous Control of 5'TOP mRNA Stability by 40S Ribosomes.</title>
<authorList>
<person name="Gentilella A."/>
<person name="Moron-Duran F.D."/>
<person name="Fuentes P."/>
<person name="Zweig-Rocha G."/>
<person name="Riano-Canalias F."/>
<person name="Pelletier J."/>
<person name="Ruiz M."/>
<person name="Turon G."/>
<person name="Castano J."/>
<person name="Tauler A."/>
<person name="Bueno C."/>
<person name="Menendez P."/>
<person name="Kozma S.C."/>
<person name="Thomas G."/>
</authorList>
<dbReference type="PubMed" id="28673543"/>
<dbReference type="DOI" id="10.1016/j.molcel.2017.06.005"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-260; LYS-311; LYS-531 AND LYS-703</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2018" name="Nucleic Acids Res." volume="46" first="1457" last="1469">
<title>La-related protein 1 (LARP1) repression of TOP mRNA translation is mediated through its cap-binding domain and controlled by an adjacent regulatory region.</title>
<authorList>
<person name="Philippe L."/>
<person name="Vasseur J.J."/>
<person name="Debart F."/>
<person name="Thoreen C.C."/>
</authorList>
<dbReference type="PubMed" id="29244122"/>
<dbReference type="DOI" id="10.1093/nar/gkx1237"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PABPC1 AND RPTOR</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF TYR-960</scope>
</reference>
<reference key="36" evidence="1 2">
<citation type="journal article" date="2015" name="Nucleic Acids Res." volume="43" first="8077" last="8088">
<title>The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5'TOP sequence.</title>
<authorList>
<person name="Lahr R.M."/>
<person name="Mack S.M."/>
<person name="Heroux A."/>
<person name="Blagden S.P."/>
<person name="Bousquet-Antonelli C."/>
<person name="Deragon J.M."/>
<person name="Berman A.J."/>
</authorList>
<dbReference type="PubMed" id="26206669"/>
<dbReference type="DOI" id="10.1093/nar/gkv748"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 873-1023</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>RNA-BINDING</scope>
<scope>MUTAGENESIS OF ARG-917 AND TYR-960</scope>
</reference>
<reference key="37" evidence="3 4 5">
<citation type="journal article" date="2017" name="Elife" volume="6">
<title>La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs.</title>
<authorList>
<person name="Lahr R.M."/>
<person name="Fonseca B.D."/>
<person name="Ciotti G.E."/>
<person name="Al-Ashtal H.A."/>
<person name="Jia J.J."/>
<person name="Niklaus M.R."/>
<person name="Blagden S.P."/>
<person name="Alain T."/>
<person name="Berman A.J."/>
</authorList>
<dbReference type="PubMed" id="28379136"/>
<dbReference type="DOI" id="10.7554/elife.24146"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 873-1023 IN COMPLEX WITH RNA 7-METHYLGUANOSINE CAP</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF ARG-917; TYR-960; GLU-963 AND TYR-999</scope>
</reference>
<comment type="function">
<text evidence="27 28 30 31 32 34 35 36 37">RNA-binding protein that regulates the translation of specific target mRNA species downstream of the mTORC1 complex, in function of growth signals and nutrient availability (PubMed:20430826, PubMed:23711370, PubMed:24532714, PubMed:25940091, PubMed:28650797, PubMed:28673543, PubMed:29244122). Interacts on the one hand with the 3' poly-A tails that are present in all mRNA molecules, and on the other hand with the 7-methylguanosine cap structure of mRNAs containing a 5' terminal oligopyrimidine (5'TOP) motif, which is present in mRNAs encoding ribosomal proteins and several components of the translation machinery (PubMed:23711370, PubMed:25940091, PubMed:28650797, PubMed:29244122, PubMed:26206669, PubMed:28379136). The interaction with the 5' end of mRNAs containing a 5'TOP motif leads to translational repression by preventing the binding of EIF4G1 (PubMed:25940091, PubMed:28650797, PubMed:29244122, PubMed:28379136). When mTORC1 is activated, LARP1 is phosphorylated and dissociates from the 5' untranslated region (UTR) of mRNA (PubMed:25940091, PubMed:28650797). Does not prevent binding of EIF4G1 to mRNAs that lack a 5'TOP motif (PubMed:28379136). Interacts with the free 40S ribosome subunit and with ribosomes, both monosomes and polysomes (PubMed:20430826, PubMed:24532714, PubMed:25940091, PubMed:28673543). Under normal nutrient availability, interacts primarily with the 3' untranslated region (UTR) of mRNAs encoding ribosomal proteins and increases protein synthesis (PubMed:23711370, PubMed:28650797). Associates with actively translating ribosomes and stimulates translation of mRNAs containing a 5'TOP motif, thereby regulating protein synthesis, and as a consequence, cell growth and proliferation (PubMed:20430826, PubMed:24532714). Stabilizes mRNAs species with a 5'TOP motif, which is required to prevent apoptosis (PubMed:20430826, PubMed:23711370, PubMed:25940091, PubMed:28673543).</text>
</comment>
<comment type="function">
<text evidence="33">(Microbial infection) Positively regulates the replication of dengue virus (DENV).</text>
</comment>
<comment type="subunit">
<text evidence="27 28 30 31 33 35">Interacts with PABPC1/PABP (PubMed:20430826, PubMed:24532714, PubMed:25940091, PubMed:23711370, PubMed:28650797). Interacts with EIF4A1 (PubMed:24532714). Interacts with RPTOR (PubMed:24532714, PubMed:25940091, PubMed:28650797). Recruited to the active mTORC1 complex via interaction with RPTOR (PubMed:25940091, PubMed:28650797). Inhibition of mTORC1 activity strongly reduces interaction with RPTOR and the mTORC1 complex (PubMed:25940091, PubMed:28650797). Identified in a complex with mRNA, PABPC1, EIF4E and EIF4G1 (PubMed:20430826, PubMed:28650797). Found in a complex with PABPC1 and SHFL (PubMed:26735137).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1052114">
<id>Q6PKG0</id>
</interactant>
<interactant intactId="EBI-749265">
<id>Q8N6L0</id>
<label>CCDC155</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="27 30 35">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="30 31">Cytoplasmic granule</location>
</subcellularLocation>
<text evidence="30 31">Colocalizes with RPTOR and PABPC1 in cytoplasmic granules that resemble stress granules.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q6PKG0-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q6PKG0-3</id>
<name>2</name>
<sequence type="described" ref="VSP_015114 VSP_015115"/>
</isoform>
</comment>
<comment type="induction">
<text evidence="29">Up-regulated in a number of hepatocellular carcinoma cell lines and liver cancer lesions, as well as in patients with hepatocellular carcinoma with a lower survival rate (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="30 32 34 37">The C-terminal region mediates interaction with the mRNA and polysomes (PubMed:24532714, PubMed:26206669, PubMed:28379136). It is required for translational repression of mRNAs with a 5'TOP motif (PubMed:29244122).</text>
</comment>
<comment type="domain">
<text evidence="37">The N-terminal region mediates interaction with PABPC1.</text>
</comment>
<comment type="PTM">
<text evidence="35">Phosphorylated on multiple Ser and Thr residues in response to active mTORC1. Phosphorylation is important for interaction with RPTOR and the mTORC1 complex. Phosphorylation promotes dissociation from the 5'UTR of mRNA molecules with a 5'TOP motif.</text>
</comment>
<comment type="similarity">
<text evidence="40">Belongs to the LARP family.</text>
</comment>
<comment type="caution">
<text evidence="27 28 30 31 35">Conflicting results are reported regarding the interaction with PABPC1. Some studies found that the interaction depends on the presence of mRNA (PubMed:23711370, PubMed:28650797). Others found that the interaction is direct and does not depend on the presence of mRNA (PubMed:20430826, PubMed:24532714, PubMed:25940091).</text>
</comment>
<comment type="sequence caution" evidence="40">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH33856" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="40">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="BAA34451" version="1"/>
</conflict>
<text>Aberrant splicing.</text>
</comment>
<dbReference type="EMBL" id="BC001460">
<property type="protein sequence ID" value="AAH01460.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033856">
<property type="protein sequence ID" value="AAH33856.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK091465">
<property type="protein sequence ID" value="BAC03668.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB018274">
<property type="protein sequence ID" value="BAA34451.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133034">
<property type="protein sequence ID" value="CAB61364.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4328.1">
<molecule id="Q6PKG0-3"/>
</dbReference>
<dbReference type="PIR" id="T42646">
<property type="entry name" value="T42646"/>
</dbReference>
<dbReference type="RefSeq" id="NP_056130.2">
<molecule id="Q6PKG0-3"/>
<property type="nucleotide sequence ID" value="NM_015315.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005268461.1">
<property type="nucleotide sequence ID" value="XM_005268404.3"/>
</dbReference>
<dbReference type="PDB" id="4ZC4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A/B/C/D=873-1023"/>
</dbReference>
<dbReference type="PDB" id="5C0V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=873-1023"/>
</dbReference>
<dbReference type="PDB" id="5V4R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A/B=873-1023"/>
</dbReference>
<dbReference type="PDB" id="5V7C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="B=873-1023"/>
</dbReference>
<dbReference type="PDB" id="5V87">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A/B=873-1023"/>
</dbReference>
<dbReference type="PDB" id="6PW3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.34"/>
<property type="chains" value="A/B/C/D=873-1023"/>
</dbReference>
<dbReference type="PDBsum" id="4ZC4"/>
<dbReference type="PDBsum" id="5C0V"/>
<dbReference type="PDBsum" id="5V4R"/>
<dbReference type="PDBsum" id="5V7C"/>
<dbReference type="PDBsum" id="5V87"/>
<dbReference type="PDBsum" id="6PW3"/>
<dbReference type="SMR" id="Q6PKG0"/>
<dbReference type="BioGrid" id="116947">
<property type="interactions" value="177"/>
</dbReference>
<dbReference type="CORUM" id="Q6PKG0"/>
<dbReference type="IntAct" id="Q6PKG0">
<property type="interactions" value="129"/>
</dbReference>
<dbReference type="MINT" id="Q6PKG0"/>
<dbReference type="STRING" id="9606.ENSP00000336721"/>
<dbReference type="CarbonylDB" id="Q6PKG0"/>
<dbReference type="iPTMnet" id="Q6PKG0"/>
<dbReference type="PhosphoSitePlus" id="Q6PKG0"/>
<dbReference type="SwissPalm" id="Q6PKG0"/>
<dbReference type="BioMuta" id="LARP1"/>
<dbReference type="DMDM" id="73621135"/>
<dbReference type="EPD" id="Q6PKG0"/>
<dbReference type="jPOST" id="Q6PKG0"/>
<dbReference type="MassIVE" id="Q6PKG0"/>
<dbReference type="MaxQB" id="Q6PKG0"/>
<dbReference type="PaxDb" id="Q6PKG0"/>
<dbReference type="PeptideAtlas" id="Q6PKG0"/>
<dbReference type="PRIDE" id="Q6PKG0"/>
<dbReference type="ProteomicsDB" id="67242">
<molecule id="Q6PKG0-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="67243">
<molecule id="Q6PKG0-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="28316">
<property type="antibodies" value="125 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="23367"/>
<dbReference type="Ensembl" id="ENST00000336314">
<molecule id="Q6PKG0-3"/>
<property type="protein sequence ID" value="ENSP00000336721"/>
<property type="gene ID" value="ENSG00000155506"/>
</dbReference>
<dbReference type="GeneID" id="23367"/>
<dbReference type="KEGG" id="hsa:23367"/>
<dbReference type="UCSC" id="uc003lvo.4">
<molecule id="Q6PKG0-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23367"/>
<dbReference type="DisGeNET" id="23367"/>
<dbReference type="GeneCards" id="LARP1"/>
<dbReference type="HGNC" id="HGNC:29531">
<property type="gene designation" value="LARP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000155506">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="612059">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q6PKG0"/>
<dbReference type="OpenTargets" id="ENSG00000155506"/>
<dbReference type="PharmGKB" id="PA142671564"/>
<dbReference type="eggNOG" id="KOG2590">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5193">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159577"/>
<dbReference type="HOGENOM" id="CLU_003957_1_0_1"/>
<dbReference type="InParanoid" id="Q6PKG0"/>
<dbReference type="KO" id="K18757"/>
<dbReference type="OMA" id="FINCPEF"/>
<dbReference type="OrthoDB" id="258488at2759"/>
<dbReference type="PhylomeDB" id="Q6PKG0"/>
<dbReference type="TreeFam" id="TF314516"/>
<dbReference type="ChiTaRS" id="LARP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="LARP1"/>
<dbReference type="GenomeRNAi" id="23367"/>
<dbReference type="Pharos" id="Q6PKG0">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q6PKG0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="Q6PKG0">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000155506">
<property type="expression patterns" value="Expressed in female gonad and 250 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q6PKG0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q6PKG0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010494">
<property type="term" value="C:cytoplasmic stress granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008190">
<property type="term" value="F:eukaryotic initiation factor 4E binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003730">
<property type="term" value="F:mRNA 3'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048027">
<property type="term" value="F:mRNA 5'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043024">
<property type="term" value="F:ribosomal small subunit binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000340">
<property type="term" value="F:RNA 7-methylguanosine cap binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000339">
<property type="term" value="F:RNA cap binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008494">
<property type="term" value="F:translation activator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031369">
<property type="term" value="F:translation initiation factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072752">
<property type="term" value="P:cellular response to rapamycin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048255">
<property type="term" value="P:mRNA stabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045947">
<property type="term" value="P:negative regulation of translational initiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016239">
<property type="term" value="P:positive regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045948">
<property type="term" value="P:positive regulation of translational initiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0045070">
<property type="term" value="P:positive regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990928">
<property type="term" value="P:response to amino acid starvation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031929">
<property type="term" value="P:TOR signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038202">
<property type="term" value="P:TORC1 signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006413">
<property type="term" value="P:translational initiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR006607">
<property type="entry name" value="DM15"/>
</dbReference>
<dbReference type="InterPro" id="IPR006630">
<property type="entry name" value="La_HTH"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF05383">
<property type="entry name" value="La"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00684">
<property type="entry name" value="DM15"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00715">
<property type="entry name" value="LA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50961">
<property type="entry name" value="HTH_LA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0648">Protein biosynthesis</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="14 19 20 38">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="La-related protein 1" id="PRO_0000207609">
<location>
<begin position="2"/>
<end position="1096"/>
</location>
</feature>
<feature type="domain" description="HTH La-type RNA-binding" evidence="26">
<location>
<begin position="397"/>
<end position="487"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with PABPC1" evidence="37">
<location>
<begin position="77"/>
<end position="573"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with RPTOR and for repression of mRNAs with a 5'TOP motif" evidence="37">
<location>
<begin position="574"/>
<end position="1096"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with mRNA" evidence="27 32">
<location>
<begin position="873"/>
<end position="1023"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with 7-methylguanosine mRNA cap structure" evidence="5 34">
<location>
<begin position="956"/>
<end position="999"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="1044"/>
<end position="1050"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="14 19 20 38">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 16 22">
<location>
<position position="75"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 10 11 13 16 18 21 22">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 17 18 21">
<location>
<position position="143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="165"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 18">
<location>
<position position="220"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="25">
<location>
<position position="223"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="228"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="25">
<location>
<position position="240"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="324"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17 21">
<location>
<position position="376"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 21">
<location>
<position position="517"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 17 18 21">
<location>
<position position="521"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 11 13 17 18 21 38">
<location>
<position position="526"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 18 21">
<location>
<position position="548"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="591"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 12 16 17 18 21 22">
<location>
<position position="627"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 16 17 18 22">
<location>
<position position="631"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11 17 21 22">
<location>
<position position="649"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11 16">
<location>
<position position="724"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 17 18 21 22 35">
<location>
<position position="766"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="35">
<location>
<position position="769"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="35">
<location>
<position position="770"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 13 17 18 21 38">
<location>
<position position="774"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="18">
<location>
<position position="777"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="35">
<location>
<position position="782"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="21 35">
<location>
<position position="785"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="21">
<location>
<position position="788"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="35">
<location>
<position position="797"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 16 21 35">
<location>
<position position="824"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="845"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="35">
<location>
<position position="847"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 35">
<location>
<position position="851"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="853"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="35">
<location>
<position position="861"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="25 35">
<location>
<position position="865"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="35">
<location>
<position position="868"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="15">
<location>
<position position="892"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="15">
<location>
<position position="1017"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="1040"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="35">
<location>
<position position="1058"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="1089"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="24">
<location>
<position position="260"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23 24">
<location>
<position position="311"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="24">
<location>
<position position="531"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="24">
<location>
<position position="703"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_015114" evidence="39">
<location>
<begin position="1"/>
<end position="77"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_015115" evidence="39">
<original>PLQLPGAEGPAISDGEEGGGEPGAGGGAAGAAGAGRRDFVEAPPPKVNPWTKNALPPVLTTVNGQSP</original>
<variation>MLWRVLLSKRPPFPHPELDFQEAPIPSCPGRLPGRKNSVALAAAPRKEPTGDREKPLPFPVLAPFSN</variation>
<location>
<begin position="78"/>
<end position="144"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with PABPC1." evidence="31">
<location>
<begin position="497"/>
<end position="507"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with PABPC1." evidence="31">
<original>F</original>
<variation>A</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by MTOR; when associated with A-769. Decreased interaction with RPTOR and impaired dissociation from the 5'UTR of mRNA molecules; when associated with A-769; A-847 and A-1058." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by MTOR; when associated with A-766. Decreased interaction with RPTOR and impaired dissociation from the 5'UTR of mRNA molecules; when associated with A-766; A-847 and A-1058." evidence="35">
<original>T</original>
<variation>A</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation mediated by Akt and RPS6KB1. Decreased interaction with RPTOR and impaired dissociation from the 5'UTR of mRNA molecules; when associated with A-766; A-769 and A-1058." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="847"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes RNA binding. Abolishes inhibition of EIF4G1 binding to mRNA molecules with a 5'TOP motif; when associated with A-960." evidence="32 34">
<original>R</original>
<variation>E</variation>
<location>
<position position="917"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes RNA binding. Abolishes translational repression of mRNAs with a 5'TOP motif. Abolishes inhibition of EIF4G1 binding to mRNA molecules with a 5'TOP motif; when associated with E-917." evidence="32 34 37">
<original>Y</original>
<variation>A</variation>
<location>
<position position="960"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased RNA binding." evidence="34">
<original>E</original>
<variation>R</variation>
<location>
<position position="963"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with RPTOR." evidence="31">
<location>
<begin position="966"/>
<end position="970"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with RPTOR." evidence="31">
<original>F</original>
<variation>A</variation>
<location>
<position position="966"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased RNA binding." evidence="34">
<original>Y</original>
<variation>A</variation>
<location>
<position position="999"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation mediated by AKT and RPS6KB1. Decreased interaction with RPTOR and impaired dissociation from the 5'UTR of mRNA molecules; when associated with A-766; A-769 and A-847." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="1058"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAH33856." ref="1" evidence="40">
<original>RNT</original>
<variation>TRP</variation>
<location>
<begin position="778"/>
<end position="780"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAB61364." ref="5" evidence="40">
<original>V</original>
<variation>L</variation>
<location>
<position position="979"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="875"/>
<end position="880"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="882"/>
<end position="884"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="887"/>
<end position="904"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="906"/>
<end position="908"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="910"/>
<end position="925"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="929"/>
<end position="945"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="949"/>
<end position="964"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="968"/>
<end position="983"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="988"/>
<end position="999"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1001"/>
<end position="1004"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1009"/>
<end position="1017"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ZC4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5C0V"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5V4R"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5V7C"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5V87"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6PW3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17693683"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q6ZQ58"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00332"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20430826"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23711370"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24159927"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24532714"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25940091"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26206669"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26735137"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28379136"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28650797"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28673543"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29244122"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305"/>
<sequence length="1096" mass="123510" checksum="CA3E9D30BBC101B7" modified="2005-08-16" version="2">MATQVEPLLPGGATLLQAEEHGGLVRKKPPPAPEGKGEPGPNDVRGGEPDGSARRPRPPCAKPHKEGTGQQERESPRPLQLPGAEGPAISDGEEGGGEPGAGGGAAGAAGAGRRDFVEAPPPKVNPWTKNALPPVLTTVNGQSPPEHSAPAKVVRAAVPKQRKGSKVGDFGDAINWPTPGEIAHKSVQPQSHKPQPTRKLPPKKDMKEQEKGEGSDSKESPKTKSDESGEEKNGDEDCQRGGQKKKGNKHKWVPLQIDMKPEVPREKLASRPTRPPEPRHIPANRGEIKGSESATYVPVAPPTPAWQPEIKPEPAWHDQDETSSVKSDGAGGARASFRGRGRGRGRGRGRGRGGTRTHFDYQFGYRKFDGVEGPRTPKYMNNITYYFDNVSSTELYSVDQELLKDYIKRQIEYYFSVDNLERDFFLRRKMDADGFLPITLIASFHRVQALTTDISLIFAALKDSKVVEIVDEKVRRREEPEKWPLPPIVDYSQTDFSQLLNCPEFVPRQHYQKETESAPGSPRAVTPVPTKTEEVSNLKTLPKGLSASLPDLDSENWIEVKKRPRPSPARPKKSEESRFSHLTSLPQQLPSQQLMSKDQDEQEELDFLFDEEMEQMDGRKNTFTAWSDEESDYEIDDRDVNKILIVTQTPHYMRRHPGGDRTGNHTSRAKMSAELAKVINDGLFYYEQDLWAEKFEPEYSQIKQEVENFKKVNMISREQFDTLTPEPPVDPNQEVPPGPPRFQQVPTDALANKLFGAPEPSTIARSLPTTVPESPNYRNTRTPRTPRTPQLKDSSQTSRFYPVVKEGRTLDAKMPRKRKTRHSSNPPLESHVGWVMDSREHRPRTASISSSPSEGTPTVGSYGCTPQSLPKFQHPSHELLKENGFTQHVYHKYRRRCLNERKRLGIGQSQEMNTLFRFWSFFLRDHFNKKMYEEFKQLALEDAKEGYRYGLECLFRYYSYGLEKKFRLDIFKDFQEETVKDYEAGQLYGLEKFWAFLKYSKAKNLDIDPKLQEYLGKFRRLEDFRVDPPMGEEGNHKRHSVVAGGGGGEGRKRCPSQSSSRPAAMISQPPTPPTGQPVREDAKWTSQHSNTQTLGK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>